Skip to main content

Advertisement

Table 9 action profile of human insulin and human insulin analogs

From: Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society

Human
Insulins
Insulin Type Onset Action peak Duration of action
Rapid-acting insulin analogs Glulisine
(Apidra®)
<5-15 minutes 1 hour 4 hours
  Lispro
(Humalog®)
<15 minutes 0.5-1.5 hour 2-4 hours
  Aspart
(NovoRapid®)
5-10 minutes 1-3 hours 3-5 hours
Short acting insulin Regular
(Novolin® R, Humulin® R)
30-60 minutes 2-3 hours 3-6 hours
Intermediate acting insulin NPH (Novolin® N Humulin® N) 2-4 hours 4-10 hours 10-16 hours
Long-acting insulin analogs Glargine
(Lantus®)
1-2 hours None Up to 24 hours
  Detemir
(Levemir®)
1-2 hours None Up to 24 hours
  1. This table presents only a partial list of commercial medications of various drugs and does not represent a specific recommendation of any commercial brand.